Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Sep. 30, 2014
CURRENT ASSETS
Cash	$ 589,847	$ 502
Prepaid Expenses	15,000	15,000
Note Receivable	12,051	10,422
Interest Receivable	784	233
Total Current Assets	617,682	26,157
OTHER ASSETS
Deposits	4,200	4,200
Available for Sale Securities	2,000	3,000
Total Other Assets	6,200	7,200
TOTAL ASSETS	623,882	33,357
CURRENT LIABILITIES
Accounts Payable	156,680	158,492
Notes Payable	332,186	379,233
Bank Overdraft	0	6,137
Accrued Payroll	664,595	587,094
Accrued Payroll Taxes	45,521	51,117
Accrued Interest	301,952	271,495
Accrued Rent	5,000
Accrued Expenses	5,000	5,000
Convertible Note Payable Net of Unamortized Discount	84,733	97,701
Due to Affiliate	0	0
Due to Subsidiary Shareholder	0	0
Current portion, note payable to affiliated party	1,000	1,000
Total Current Liabilities	1,598,667	1,557,269
Total Liabilities	1,598,667	1,557,269
STOCKHOLDERS EQUITY (DEFICIT)
Preferred Stock ($0.0001 par value) 20,000,000 shares authorized; 2,063,821 issued and outstanding as of March 31, 2015 and September 30, 2014	207	207
Series AA Preferred ($0.0001 par value) 100,000 shares authorized; 94,852 issued and outstanding as of March 31, 2015 and September 30, 2014	9	9
Series AAA Preferred ($0.0001 par value) 1,000,000 shares authorized 40,000 shares issued and outstanding as of March 31, 2015 and September 30, 2014	4	4
Series B Preferred Shares ($0.0001 par value) 2,000,000 shares authorized; 725,409 issued and outstanding as of March 31, 2015 and September 30, 2014 respectively	73	73
Common Stock ($0.0001 par value) 5,000,000,000 shares authorized; 4,032,931,245 and 3,079,900,942 issued and outstanding as of March 31, 2015 and September 30, 2014 respectively	403,292	307,989
Non Voting Convertible Preferred Stock ($1 Par value) 200,000 shares authorized; 0 shares issued and outstanding as of March 31, 2015 and September 30, 2014	0	0
Additional Paid in capital	26,789,471	16,510,439
Contributed Capital	509,355	509,355
Retained Earnings (Deficit)	12,224,991	22,461,356
Accumulated Other Comprehensive Income (Loss)	(41,334,361)	(41,333,361)
Total Stockholders' Equity (Deficit) Biomatrix Scientific Group, Inc.	(1,406,959)	(1,543,929)
Noncontrolling Interest in subsidiary	432,174	20,017
Total Stockholders' Equity	(974,785)	(1,523,912)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ 623,882	$ 33,357